Literature DB >> 18410881

Public health approach to addressing hyperphosphatemia among dialysis patients.

Ashwini R Sehgal1, Catherine Sullivan, Janeen B Leon, Karil Bialostosky.   

Abstract

Elevated serum phosphorus levels are a major source of morbidity and mortality for the 350,000 Americans receiving chronic dialysis treatment. Despite the widespread application of medical and behavioral interventions, the prevalence of hyperphosphatemia remains exceedingly high. At first glance, a public health perspective may seem inappropriate for addressing a disorder of mineral metabolism among patients receiving a life-sustaining treatment. However, we analyzed this topic from a public health perspective and identified many opportunities to improve the management of hyperphosphatemia, including (1) media and cultural messages about food, (2) the availability of appropriate foods and medications, (3) physical structures such as the location of products in grocery stores, and (4) social structures such as food-labeling laws.

Entities:  

Mesh:

Year:  2008        PMID: 18410881      PMCID: PMC2391002          DOI: 10.1053/j.jrn.2007.12.002

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  41 in total

1.  A structural model of health behavior: a pragmatic approach to explain and influence health behaviors at the population level.

Authors:  D A Cohen; R A Scribner; T A Farley
Journal:  Prev Med       Date:  2000-02       Impact factor: 4.018

Review 2.  The institute of medicine's "dietary reference intake" for phosphorus: a critical perspective.

Authors:  L Sax
Journal:  J Am Coll Nutr       Date:  2001-08       Impact factor: 3.169

Review 3.  Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients.

Authors:  N W Levin; N A Hoenich
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-09       Impact factor: 2.894

Review 4.  Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.

Authors:  E Slatopolsky; A Brown; A Dusso
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

5.  Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire.

Authors:  Kamyar Kalantar-Zadeh; Joel D Kopple; Sunaina Deepak; Donald Block; Gladys Block
Journal:  J Ren Nutr       Date:  2002-01       Impact factor: 3.655

6.  Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

Authors:  Santhi K Ganesh; Austin G Stack; Nathan W Levin; Tempie Hulbert-Shearon; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

7.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

Authors:  W G Goodman; J Goldin; B D Kuizon; C Yoon; B Gales; D Sider; Y Wang; J Chung; A Emerick; L Greaser; R M Elashoff; I B Salusky
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

Review 8.  Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients.

Authors:  G A Block
Journal:  Clin Nephrol       Date:  2000-10       Impact factor: 0.975

Review 9.  Surgical management of secondary hyperparathyroidism.

Authors:  John A Olson; George S Leight
Journal:  Adv Ren Replace Ther       Date:  2002-07

Review 10.  Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure.

Authors:  Hartmut H Malluche; Hanna Mawad; Nicholas J Koszewski
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

View more
  8 in total

1.  Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.

Authors:  Orlando M Gutiérrez; Tamara Isakova; Gwen Enfield; Myles Wolf
Journal:  J Ren Nutr       Date:  2010-05-26       Impact factor: 3.655

Review 2.  Effects of Excessive Dietary Phosphorus Intake on Bone Health.

Authors:  Colby J Vorland; Elizabeth R Stremke; Ranjani N Moorthi; Kathleen M Hill Gallant
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

3.  Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention.

Authors:  Kosmas I Paraskevas; Ioannis Kotsikoris; Sotirios A Koupidis; Alexandros A Tzovaras; Dimitri P Mikhailidis
Journal:  Int Urol Nephrol       Date:  2010-06-24       Impact factor: 2.370

4.  Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.

Authors:  Takashi Shimada; Itaru Urakawa; Tamara Isakova; Yuji Yamazaki; Michael Epstein; Katherine Wesseling-Perry; Myles Wolf; Isidro B Salusky; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

5.  Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis.

Authors:  Richard A Sherman; Ojas Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 8.237

6.  Phosphorus binders and survival on hemodialysis.

Authors:  Tamara Isakova; Orlando M Gutiérrez; Yuchiao Chang; Anand Shah; Hector Tamez; Kelsey Smith; Ravi Thadhani; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

7.  Elevation of phosphate levels impairs skeletal myoblast differentiation.

Authors:  Adalbert Raimann; Alexander Dangl; Alireza Javanmardi; Susanne Greber-Platzer; Monika Egerbacher; Peter Pietschmann; Gabriele Haeusler
Journal:  Cell Tissue Res       Date:  2020-07-28       Impact factor: 5.249

Review 8.  Sirtuin-1 and Its Relevance in Vascular Calcification.

Authors:  Chien-Lin Lu; Min-Tser Liao; Yi-Chou Hou; Yu-Wei Fang; Cai-Mei Zheng; Wen-Chih Liu; Chia-Ter Chao; Kuo-Cheng Lu; Yee-Yung Ng
Journal:  Int J Mol Sci       Date:  2020-02-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.